Development of Medical Countermeasures to Middle East Respiratory Syndrome Coronavirus
Preclinical development of and research on potential Middle East respiratory syndrome coronavirus (MERS-CoV) medical countermeasures remain preliminary; advancements are needed before most countermeasures are ready to be tested in human clinical trials. Research priorities include standardization of...
Main Authors: | Timothy M. Uyeki, Karl J. Erlandson, George Korch, Michael O’Hara, Michael Wathen, Jean Hu-Primmer, Sally Hojvat, Erik J. Stemmy, Armen Donabedian |
---|---|
Format: | Article |
Language: | English |
Published: |
Centers for Disease Control and Prevention
2016-07-01
|
Series: | Emerging Infectious Diseases |
Subjects: | |
Online Access: | https://wwwnc.cdc.gov/eid/article/22/7/16-0022_article |
Similar Items
-
Exposure-related, global alterations in innate and adaptive immunity; a consideration for re-use of non-human primates in research
by: François A. Bates, et al.
Published: (2021-03-01) -
Histiocytic Sarcoma in a Captive Hybrid Orangutan (<i>Pongo</i> sp.): Morphological and Immunohistochemical Features
by: Valentina Galietta, et al.
Published: (2024-03-01) -
The Post-Acute Phase of SARS-CoV-2 Infection in Two Macaque Species Is Associated with Signs of Ongoing Virus Replication and Pathology in Pulmonary and Extrapulmonary Tissues
by: Kinga P. Böszörményi, et al.
Published: (2021-08-01) -
Electronic countermeasures /
by: Boyd, J. A. (Joseph Aubrey), 1921-, et al.
Published: ([197) -
Quantitative Rapid Test for Detection and Monitoring of Active Pulmonary Tuberculosis in Nonhuman Primates
by: Zijie Zhou, et al.
Published: (2021-12-01)